{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:26:15Z","timestamp":1789208775431,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ccm.2015.11.004","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T18:19:40Z","timestamp":1450981180000},"page":"109-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Gastrointestinal Disorders in Cystic Fibrosis"],"prefix":"10.1016","volume":"37","author":[{"given":"David N.","family":"Assis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ccm.2015.11.004_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study","volume":"56","author":"Andersen","year":"1938","journal-title":"Am J Dis Child"},{"issue":"4","key":"10.1016\/j.ccm.2015.11.004_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-0636","article-title":"Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry","volume":"161","author":"MacKenzie","year":"2014","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.ccm.2015.11.004_bib3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A\u00a0CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2015.11.004_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccm.2015.11.004_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2012.11.010","article-title":"Cirrhosis and other liver disease in cystic fibrosis","volume":"12","author":"Flass","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MCP.0b013e3282f10a16","article-title":"Liver disease in cystic fibrosis","volume":"13","author":"Colombo","year":"2007","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ccm.2015.11.004_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jcf.2010.06.004","article-title":"Characteristics of gastroesophageal reflux in adults with cystic fibrosis","volume":"9","author":"Sabati","year":"2010","journal-title":"J\u00a0Cyst Fibros"},{"issue":"1","key":"10.1016\/j.ccm.2015.11.004_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/014107689809100103","article-title":"Prevalence and mechanisms of gastro-oesophageal reflux in adult cystic fibrosis patients","volume":"91","author":"Ledson","year":"1998","journal-title":"J\u00a0R Soc Med"},{"issue":"7","key":"10.1016\/j.ccm.2015.11.004_bib10","first-page":"CR529","article-title":"Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis","volume":"8","author":"Brodzicki","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ccm.2015.11.004_bib11","series-title":"Patient registry, 2012 annual data report to the center directors","author":"Foundation, CF","year":"2012"},{"issue":"9","key":"10.1016\/j.ccm.2015.11.004_bib12","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/ajg.2012.213","article-title":"Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis","volume":"107","author":"Pauwels","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.ccm.2015.11.004_bib13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gut.2007.146134","article-title":"Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis","volume":"57","author":"Blondeau","year":"2008","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib14","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1378\/chest.11-1573","article-title":"Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis","volume":"141","author":"Pauwels","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2015.11.004_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1183\/09031936.01.00068901","article-title":"Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis","volume":"18","author":"Navarro","year":"2001","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ppul.21598","article-title":"The impact of reflux burden on Pseudomonas positivity in children with\u00a0cystic fibrosis","volume":"47","author":"Palm","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.ccm.2015.11.004_bib17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1183\/09031936.00064807","article-title":"Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection","volume":"31","author":"Blondeau","year":"2008","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1513\/AnnalsATS.201401-044FR","article-title":"Prevalence of gastroesophageal reflux in cystic fibrosis and implications for lung disease","volume":"11","author":"Robinson","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.ccm.2015.11.004_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/17512433.2013.811206","article-title":"Perils and pitfalls of long-term effects of proton pump inhibitors","volume":"6","author":"Wilhelm","year":"2013","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.ccm.2015.11.004_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jpeds.2009.06.040","article-title":"Gastric acid inhibition for fat malabsorption or gastroesophageal reflux disease in cystic fibrosis: longitudinal effect on bacterial colonization and pulmonary function","volume":"155","author":"van der Doef","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ccm.2015.11.004_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2466-14-21","article-title":"Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis","volume":"14","author":"Dimango","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ccm.2015.11.004_bib22","unstructured":"Orkambi(R), Orkambi [package insert]. Boston: Vertex Pharmaceuticals; 2015."},{"issue":"8","key":"10.1016\/j.ccm.2015.11.004_bib23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jpedsurg.2007.03.030","article-title":"Outcomes of fundoplication in children with cystic fibrosis","volume":"42","author":"Boesch","year":"2007","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.ccm.2015.11.004_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-9974-5-1","article-title":"Cough in adult cystic fibrosis: diagnosis and response to fundoplication","volume":"5","author":"Fathi","year":"2009","journal-title":"Cough"},{"issue":"8","key":"10.1016\/j.ccm.2015.11.004_bib25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/gut.52.8.1159","article-title":"Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas","volume":"52","author":"Ahmed","year":"2003","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ccm.2015.11.004_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11894-005-0039-4","article-title":"Pancreatic exocrine function in patients with cystic fibrosis","volume":"7","author":"Baker","year":"2005","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"10.1016\/j.ccm.2015.11.004_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1067\/mpd.2000.107891","article-title":"Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the cystic fibrosis foundation national CF patient registry","volume":"137","author":"Zemel","year":"2000","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1067\/mpd.2003.152","article-title":"Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis","volume":"142","author":"Konstan","year":"2003","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.ccm.2015.11.004_bib29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpeds.2004.04.049","article-title":"Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis","volume":"145","author":"Borowitz","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.ccm.2015.11.004_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1067\/mpd.2002.124829","article-title":"How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?","volume":"141","author":"Beharry","year":"2002","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MCP.0b013e3283659ef2","article-title":"Intestinal complications of cystic fibrosis","volume":"19","author":"Borowitz","year":"2013","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib32","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1053\/gast.2002.37042","article-title":"Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis","volume":"123","author":"Durno","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ccm.2015.11.004_bib33","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jpeds.2012.10.008","article-title":"Evolution of pancreatic function during the first year in infants with cystic fibrosis","volume":"162","author":"O'Sullivan","year":"2013","journal-title":"J\u00a0Pediatr"},{"issue":"18","key":"10.1016\/j.ccm.2015.11.004_bib34","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM199705013361803","article-title":"High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis","volume":"336","author":"FitzSimmons","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcf.2013.05.011","article-title":"Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a reconsideration","volume":"12","author":"Borowitz","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"issue":"5","key":"10.1016\/j.ccm.2015.11.004_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1651-2227.1998.tb01503.x","article-title":"Effects of a proton-pump inhibitor in cystic fibrosis","volume":"87","author":"Tran","year":"1998","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/MPA.0b013e31828784ef","article-title":"Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase\/pancreatin (CREON(R)) in patients with pancreatic exocrine insufficiency","volume":"42","author":"Sander-Struckmeier","year":"2013","journal-title":"Pancreas"},{"issue":"6 Suppl","key":"10.1016\/j.ccm.2015.11.004_bib38","first-page":"S73","article-title":"Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Cystic Fibrosis Foundation","year":"2009","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.ccm.2015.11.004_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.gastro.2010.09.046","article-title":"Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis","volume":"140","author":"Ooi","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ccm.2015.11.004_bib40","first-page":"207","article-title":"Origins of chloride and bicarbonate secretory defects in the cystic fibrosis pancreas, as suggested by pancreatic function studies on control and CF subjects with preserved pancreatic function","volume":"12","author":"Kopelman","year":"1989","journal-title":"Clin Invest Med"},{"issue":"3\u20134","key":"10.1016\/j.ccm.2015.11.004_bib41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00439-005-0059-z","article-title":"The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis","volume":"118","author":"Bishop","year":"2005","journal-title":"Hum Genet"},{"issue":"10","key":"10.1016\/j.ccm.2015.11.004_bib42","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/gut.2005.064808","article-title":"Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls","volume":"54","author":"Weiss","year":"2005","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ccm.2015.11.004_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ajg.2011.424","article-title":"Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations","volume":"107","author":"Bertin","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ccm.2015.11.004_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/j.gastro.2014.11.002","article-title":"Alcohol disrupts levels and function of the cystic fibrosis transmembrane conductance regulator to promote development of pancreatitis","volume":"148","author":"Mal\u00e9th","year":"2015","journal-title":"Gastroenterology"},{"issue":"8\u20139","key":"10.1016\/j.ccm.2015.11.004_bib45","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365521.2012.699548","article-title":"Gastrointestinal transit times and motility in patients with cystic fibrosis","volume":"47","author":"Hedsund","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.ccm.2015.11.004_bib46","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s10620-012-2209-1","article-title":"Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule","volume":"58","author":"Gelfond","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.ccm.2015.11.004_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1440-1754.1998.00159.x","article-title":"Bowel dysfunction in cystic fibrosis: importance of breath testing","volume":"34","author":"Lewindon","year":"1998","journal-title":"J\u00a0Paediatr Child Health"},{"issue":"5","key":"10.1016\/j.ccm.2015.11.004_bib48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3109\/00365513.2010.486869","article-title":"Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis","volume":"70","author":"Lisowska","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"10.1016\/j.ccm.2015.11.004_bib49","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MPG.0b013e31802c0ceb","article-title":"Risk factors for small bowel bacterial overgrowth in cystic fibrosis","volume":"44","author":"Fridge","year":"2007","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"8","key":"10.1016\/j.ccm.2015.11.004_bib50","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s10620-008-0559-5","article-title":"Application of the glucose hydrogen breath test for the detection of bacterial overgrowth in patients with cystic fibrosis\u2013a reliable method?","volume":"54","author":"Schneider","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.ccm.2015.11.004_bib51","first-page":"631","article-title":"Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection","volume":"56","author":"Lisowska","year":"2009","journal-title":"Acta Biochim Pol"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcf.2011.06.008","article-title":"Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth","volume":"10","author":"Lisowska","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1695-4033(08)75231-7","article-title":"Improvement of intestinal function in cystic fibrosis patients using probiotics","volume":"69","author":"Infante Pina","year":"2008","journal-title":"An Pediatr (Barc)"},{"issue":"7","key":"10.1016\/j.ccm.2015.11.004_bib54","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2004.02174.x","article-title":"Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration","volume":"20","author":"Bruzzese","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ccm.2015.11.004_bib55","first-page":"475","article-title":"The effect of probiotics on fecal calprotectin in patients with cystic fibrosis","volume":"55","author":"Fallahi","year":"2013","journal-title":"Turk J Pediatr"},{"issue":"2","key":"10.1016\/j.ccm.2015.11.004_bib56","doi-asserted-by":"crossref","first-page":"e87796","DOI":"10.1371\/journal.pone.0087796","article-title":"Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with lactobacillus GG: a randomised clinical trial","volume":"9","author":"Bruzzese","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib57","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jcf.2014.02.007","article-title":"Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study","volume":"13","author":"del Campo","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"issue":"1","key":"10.1016\/j.ccm.2015.11.004_bib58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPG.0000000000000187","article-title":"Lactobacillus reuteri ATCC55730 in cystic fibrosis","volume":"58","author":"Di Nardo","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.ccm.2015.11.004_bib59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MPG.0b013e3181a6e01d","article-title":"Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS","volume":"50","author":"Houwen","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2015.11.004_bib60","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1569-1993(11)60005-2","article-title":"Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients","volume":"10","author":"Colombo","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3","key":"10.1016\/j.ccm.2015.11.004_bib61","first-page":"356","article-title":"The age-related incidence of meconium ileus equivalent in a cystic fibrosis population: the impact of high-energy intake","volume":"11","author":"Andersen","year":"1990","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.ccm.2015.11.004_bib62","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1542-3565(04)00169-7","article-title":"Distal intestinal obstruction syndrome in adults with cystic fibrosis","volume":"2","author":"Dray","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ccm.2015.11.004_bib63","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1345\/aph.1Q219","article-title":"Lubiprostone for constipation in adults with cystic fibrosis: a pilot study","volume":"45","author":"O'Brien","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.ccm.2015.11.004_bib64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.ccm.2015.11.004_bib65","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199502233320803","article-title":"The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group","volume":"332","author":"Neglia","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccm.2015.11.004_bib66","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/jgh.12842","article-title":"Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?","volume":"30","author":"Pang","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ccm.2015.11.004_bib67","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1097\/MCG.0000000000000034","article-title":"Early colon screening of adult patients with cystic fibrosis reveals high incidence of adenomatous colon polyps","volume":"48","author":"Billings","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.ccm.2015.11.004_bib68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcf.2015.01.006","article-title":"Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation","volume":"14","author":"Bodewes","year":"2015","journal-title":"J\u00a0Cyst Fibros"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523115001434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523115001434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:52:34Z","timestamp":1759452754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523115001434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0272523115001434"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2015.11.004","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal Disorders in Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2015.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}